Doctor profile · Federal record
Dr. So Yeon Paek, M.D.
Dermatology Physician (CMS: Dermatology) · Dermatology Physician · Dallas, TX
- NPI 1790079184
- Accepts Medicare
- MIPS 96.8 / 100 · 2023
- 15 yrs in practice
- Licensed in 2 states
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
3900 Junius St Ste 420
Dallas, TX 752461615
(972) 200-7446
fax (972) 798-2142
Credentials & registration
- NPI registered
- June 2011 — 15 yrs on file
- Profile last updated
- April 14, 2025
- Year of graduation
- 2011 — 15 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State licenses (2)
- Texas #R3729 · Rhode Island #MD15065
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1790079184. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
5,424
Distinct HCPCS
10
Medicare allowed
$182,956
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J7345 |
Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | 2,600 | 11 | $2 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 1,191 | 182 | $6 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 347 | 233 | $118 | |
17110 |
Destruction of skin growth, 1-14 growths | 299 | 213 | $106 | |
17000 |
Destruction of precancer skin growth, 1 growth | 293 | 207 | $39 | |
11102 |
Biopsy of related skin growth, first growth | 180 | 140 | $66 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 93 | 63 | $157 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 87 | 66 | $83 | |
11103 |
Biopsy of related skin growth, each additional growth | 80 | 40 | $47 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 64 | 52 | $162 |
In context: peer comparison
Among 51 peers in Dallas Dermatology Physician, average services per provider: 218. This provider delivers 25× the peer median.Open Payments
Industry payments received
All-time total
$162,633
Transactions
244
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 125 | $127,452.92 | |
| Novartis Pharmaceuticals Corporation | 17 | $13,455.07 | |
| Janssen Biotech, INC. | 16 | $10,689.42 | |
| Ucb, INC. | 16 | $9,198.81 | |
| Pfizer INC. | 19 | $330.91 | |
| Sun Pharmaceutical Industries INC. | 9 | $279.89 | |
| E.R. Squibb & Sons, L.L.C. | 11 | $278.78 | |
| Lilly USA, LLC | 7 | $160.15 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | 1 | $152.22 | |
| Janssen Scientific Affairs, LLC | 3 | $141.83 | |
| Paratek Pharmaceuticals, INC. | 10 | $136.18 | |
| Amgen INC. | 4 | $91.38 | |
| Incyte Corporation | 2 | $44.20 | |
| Mayne Pharma Commercial LLC | 2 | $38.49 | |
| Organon LLC | 2 | $30.17 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
158
Patients
73
Total drug cost
$286,115
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 47 | 21 | $681 |
| Triamcinolone Acetonide | Generic | 29 | 20 | $323 |
| Clobetasol Propionate | Generic | 23 | 20 | $2,099 |
| Mupirocin | Generic | 17 | 12 | $238 |
| Rinvoq (Upadacitinib) | Brand | 15 | 0 | $98,748 |
| Nystatin | Generic | 14 | 0 | $412 |
| Humira(Cf) Pen (Adalimumab) | Brand | 13 | 0 | $183,614 |
Frequently asked questions
What is Dr. So Yeon Paek's medical specialty?
Dr. So Yeon Paek practices Dermatology Physician in Dallas, TX.
Where does Dr. So Yeon Paek practice?
Dr. So Yeon Paek practices at 3900 Junius St Ste 420, Dallas, TX 752461615. Office phone: 9722007446.
What is Dr. So Yeon Paek's NPI?
Dr. So Yeon Paek's National Provider Identifier (NPI) is 1790079184, issued by NPPES.
Does Dr. So Yeon Paek accept Medicare assignment?
Yes. Dr. So Yeon Paek accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. So Yeon Paek commonly perform?
Top Medicare-reported procedures in 2023: Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg (HCPCS J7345); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.